lung cancer | |||||
新闻 | |||||
| |||||
Bilateral Mediastinal Lymphadenectomy Is Associated With Potential Survival Advantages in ... PURPOSEThe optimal lymphadenectomy approach for solid-dominant stage I non–small cell lung cancer (NSCLC) is controversial.
| |||||
Rybrevant Plus Lazcluze Improves Survival for EGFR+ NSCLC - Cure Today Image of lung cancer. First-line Rybrevant plus Lazcluze generates improves in mutated advanced or metastatic NSCLC. Among patients with locally ...
| |||||
FDA Clears Investigational New Drug Application for REC-4539 in SCLC The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small cell lung cancer and ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment